GH logo

Guardant Health, Inc. Common Stock

GH

GH: Guardant Health, based in Redwood City, California, provides cancer blood tests and analytics for clinical and research use, and the firm maintains research partnerships with large biopharmaceutical companies. The company offers Guardant 360, a blood-based (liquid biopsy) test for treatment selection in advanced stage cancer, and Guardant Omni, a broader gene panel for immuno-oncology research. The company's pipeline includes Guardant Reveal (formerly Lunar-1), for cancer recurrence detection in survivors, and Lunar-2, a liquid biopsy for early detection of cancer in higher-risk individuals, with an initial focus on colorectal cancer. Additionally, Guardant offers research development services. In 2022, the United States accounted for 94% of revenue, and other markets the remaining 6%.

more

Show GH Financials

Chart and Financial Data provided by TradingView

All
Government
Consumer Interest
SEC Filings
ESG/Other
Congress Trading

Recent trades of GH by members of U.S. Congress

Politician Type Traded
Donald Sternoff Beyer Jr. House / D Sale $1,001 - $15,000 Feb. 28, 2022
Donald Sternoff Beyer Jr. House / D Sale $1,001 - $15,000 Jan. 13, 2022
Donald Sternoff Beyer Jr. House / D Sale $1,001 - $15,000 Dec. 22, 2021
Donald Sternoff Beyer Jr House / D Purchase $1,001 - $15,000 Nov. 02, 2020
Donald Sternoff Beyer Jr House / D Purchase $1,001 - $15,000 Oct. 22, 2020
Donald Sternoff Beyer Jr House / D Purchase $1,001 - $15,000 Oct. 05, 2020
Donald Sternoff Beyer Jr House / D Sale $1,001 - $15,000 Jul. 14, 2020
Donald Sternoff Beyer Jr House / D Sale $1,001 - $15,000 May. 01, 2020
Donald Sternoff Beyer Jr House / D Sale $1,001 - $15,000 Apr. 27, 2020
Donald Sternoff Beyer Jr House / D Purchase $1,001 - $15,000 Feb. 14, 2020
Whale Activity

Recently reported changes by institutional investors

Insider Trading

Quarterly net insider trading by GH's directors and management

Corporate Lobbying

Government lobbying spending instances

  • $260,000 Jul 20, 2023 Issue: Health Issues Medicare/Medicaid
  • $260,000 Apr 21, 2023 Issue: Health Issues Medicare/Medicaid
  • $220,000 Jan 19, 2023 Issue: Veterans Labor Issues/Antitrust/Workplace Health Issues Medicare/Medicaid
  • $220,000 Oct 20, 2022 Issue: Veterans Labor Issues/Antitrust/Workplace Health Issues Medicare/Medicaid
  • $220,000 Jul 20, 2022 Issue: Labor Issues/Antitrust/Workplace Health Issues Medicare/Medicaid
  • $220,000 Apr 20, 2022 Issue: Health Issues Medicare/Medicaid
  • $200,000 Jan 21, 2022 Issue: None
  • $200,000 Oct 19, 2021 Issue: None
  • $200,000 Jul 20, 2021 Issue: None
  • $200,000 Apr 21, 2021 Issue: None
  • $160,000 Jan 20, 2021 Issue: None
  • $160,000 Oct 20, 2020 Issue: None
  • $180,000 Jul 20, 2020 Issue: None
  • $167,500 Apr 20, 2020 Issue: None
  • $70,000 Jan 20, 2020 Issue: None
  • $70,000 Oct 20, 2019 Issue: Medicare/Medicaid Health Issues
  • $60,000 Jul 22, 2019 Issue: Veterans Health Issues Medicare/Medicaid
  • $60,000 Apr 17, 2019 Issue: Veterans Health Issues
  • $60,000 Jan 18, 2019 Issue: Budget/Appropriations Health Issues Veterans
  • $60,000 Oct 18, 2018 Issue: Health Issues
  • $60,000 Jul 20, 2018 Issue: Health Issues
  • $60,000 Apr 20, 2018 Issue: Health Issues Medicare/Medicaid
  • $60,000 Jan 22, 2018 Issue: Health Issues Medicare/Medicaid
  • $60,000 Oct 20, 2017 Issue: Health Issues Medicare/Medicaid
  • $60,000 Jul 19, 2017 Issue: Health Issues Medicare/Medicaid
  • $60,000 Apr 20, 2017 Issue: Health Issues Medicare/Medicaid
  • $20,000 Jan 18, 2017 Issue: Health Issues
U.S. Patents

New patents grants

  • Patent Title: Correcting for deamination-induced sequence errors Aug. 08, 2023
  • Patent Title: Methods and systems for detecting genetic variants Jun. 06, 2023
  • Patent Title: Systems and methods to detect rare mutations and copy number variation Jun. 06, 2023
  • Patent Title: Method for the detection of cancer Jun. 06, 2023
  • Patent Title: Methods and systems for detecting genetic variants May. 16, 2023
  • Patent Title: Methods for early detection of cancer May. 09, 2023
  • Patent Title: Compositions and methods for isolating cell-free dna May. 09, 2023
  • Patent Title: Methods and systems for detecting genetic variants May. 02, 2023
  • Patent Title: Methods and systems for detecting genetic variants May. 02, 2023
  • Patent Title: Cancer evolution detection and diagnostic Apr. 04, 2023
  • Patent Title: Methods and systems for detecting genetic variants Mar. 21, 2023
  • Patent Title: Systems and methods to detect rare mutations and copy number variation Feb. 14, 2023
  • Patent Title: Machine learning for somatic single nucleotide variant detection in cell-free tumor nucleic acid sequencing applications Dec. 13, 2022
  • Patent Title: Methods for computer processing sequence reads to detect molecular residual disease Dec. 06, 2022
  • Patent Title: Methods and systems for analyzing nucleic acid molecules Dec. 06, 2022
  • Patent Title: Methods for 3′ overhang repair Sep. 20, 2022
  • Patent Title: Systems and methods to detect rare mutations and copy number variation Sep. 20, 2022
  • Patent Title: Methods and systems for detecting genetic variants Sep. 06, 2022
  • Patent Title: Systems and methods to detect rare mutations and copy number variation Sep. 06, 2022
  • Patent Title: Methods for detecting single nucleotide variants or indels by deep sequencing Jun. 14, 2022
  • Patent Title: Methods for computer processing sequence reads to detect molecular residual disease May. 31, 2022
  • Patent Title: Cancer evolution detection and diagnostic May. 17, 2022
  • Patent Title: Systems and methods to detect rare mutations and copy number variation May. 03, 2022
  • Patent Title: Systems and methods to detect rare mutations and copy number variation May. 03, 2022
  • Patent Title: Machine learning for somatic single nucleotide variant detection in cell-free tumor nucleic acid sequencing applications Apr. 12, 2022
  • Patent Title: Cancer evolution detection and diagnostic Mar. 22, 2022
  • Patent Title: Methods to determine tumor gene copy number by analysis of cell-free dna Feb. 08, 2022
  • Patent Title: Systems and methods to detect rare mutations and copy number variation Feb. 08, 2022
  • Patent Title: Normalizing tumor mutation burden Dec. 07, 2021
  • Patent Title: Methods and systems for detecting genetic variants Oct. 19, 2021
  • Patent Title: Methods and systems for detecting genetic variants Oct. 19, 2021
  • Patent Title: Methods and systems for adjusting tumor mutational burden by tumor fraction and coverage Sep. 14, 2021
  • Patent Title: Methods and systems for detecting genetic variants Sep. 14, 2021
  • Patent Title: Systems and methods to detect rare mutations and copy number variation Aug. 17, 2021
  • Patent Title: Systems and methods to detect rare mutations and copy number variation Aug. 17, 2021
  • Patent Title: Gene mutations and copy number alterations of egfr, kras and met Aug. 10, 2021
  • Patent Title: Methods for multi-resolution analysis of cell-free nucleic acids Jul. 13, 2021
  • Patent Title: Correcting for deamination-induced sequence errors May. 18, 2021
  • Patent Title: Systems and methods to detect rare mutations and copy number variation May. 11, 2021
  • Patent Title: Systems and methods to detect rare mutations and copy number variation May. 04, 2021
  • Patent Title: Systems and methods to detect rare mutations and copy number variation Apr. 20, 2021
  • Patent Title: Systems and methods to detect rare mutations and copy number variation Mar. 30, 2021
  • Patent Title: Systems and methods to detect rare mutations and copy number variation Mar. 16, 2021
  • Patent Title: Systems and methods to detect rare mutations and copy number variation Jan. 19, 2021
  • Patent Title: Methods and systems for detecting genetic variants Jan. 12, 2021
  • Patent Title: Methods and systems for detecting genetic variants Jan. 05, 2021
  • Patent Title: Systems and methods to detect rare mutations and copy number variation Dec. 29, 2020
  • Patent Title: Systems and methods to detect rare mutations and copy number variation Dec. 29, 2020
  • Patent Title: Systems and methods to detect rare mutations and copy number variation Dec. 29, 2020
  • Patent Title: Systems and methods to detect rare mutations and copy number variation Dec. 22, 2020
Government Contracts

Federal grants, loans, and purchases

WallStreetBets

Number of mentions of GH in WallStreetBets Daily Discussion

GH News

Recent insights relating to GH

CNBC Recommendations

Recent picks made for GH stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in GH

Corporate Flights

Flights by private jets registered to GH